Porvair PLC
Registered name: PORVAIR PLC
Porvair PLC made £194m revenue and £18.2m profit in the year to 30 Nov 2025.
Porvair PLC’s revenue grew 1% to £194m in the year to 30 Nov 2025, with £18.2m profit and 1,011 employees. The company is classified under “manufacture of basic pharmaceutical products” and is based in Kings Lynn; we hold 3 years of its filed accounts.
- Status
- Active
- Location
- Kings Lynn, East of England
- Age
- 44 yrs · since 1982
- Type
- Public Limited Company
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 30 Nov 2023 | 30 Nov 2024 | 30 Nov 2025 |
|---|---|---|---|
| Disclosure | Full P&L | Full P&L | Full P&L |
| Profit & loss | |||
| Revenue (turnover) | £176m | £193m | £194m |
| Cost of sales | −£114m | −£128m | −£125m |
| Gross profit | £62.3m | £65.1m | £68.7m |
| Operating profit | £21.2m | £22.8m | £24.5m |
| Profit before tax | £20.1m | £20.9m | £23.3m |
| Profit after tax | £16m | £16.6m | £18.2m |
| Profit (best available) | £16m | £16.6m | £18.2m |
| Employees (average) | 1,009 | 1,007 | 1,011 |
| Ratios | |||
| Profit margin | 9.1% | 8.6% | 9.4% |
| Gross margin | 35.4% | 33.8% | 35.4% |
| Revenue per employee | £174k | £191k | £192k |
| Profit per employee | £15.8k | £16.5k | £18k |
| Growth (year on year) | |||
| Revenue growth | — | ▲9.4% | ▲0.7% |
| Profit growth | — | ▲4% | ▲9.4% |
| Headcount growth | — | ▼0.2% | ▲0.4% |
| Balance sheet — indirect signals, not revenue | |||
| Net assets | — | — | — |
| Source | Accounts · bulk data May 2025 | Accounts · bulk data May 2025 | Accounts · bulk data May 2026 |
How the business works
- Profit margin
- 9.4%
- Profit ÷ revenue.
- Gross margin
- 35.4%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £192k
- Revenue ÷ average employees.
- Profit per employee
- £18k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- —
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now —
- Cash at bank
- —
- Now —
- Headcount
- ▲0%
- Now 1,011
- Deferred income
- —
- Now —
- Fixed assets
- —
- Now —
Group structure
Subsidiaries (4)
- Kbiosystems LimitedRev. £4.1m · Profit £423k
- Seal Analytical LimitedRev. £1.5m · Profit £273k
- Kbioservices LimitedFigures not disclosed
- Porvair Filtration LimitedRev. — · Profit £6m
From the Persons with Significant Control register (corporate controllers only).
Sources
Latest figures from accounts for the year to 30 Nov 2025 (profit £18.2m), from the Companies House accounts bulk data published May 2026. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.